Tiziana Life Sciences Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Tiziana Life Sciences Ltd (TLSA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-11.86-17.69-15.40-23.4217.90
Depreciation & Amortization0.120.100.050.140.01
Stock Based Compensation5.972.30-1.416.0319.07
Change in Working Capital-0.55-1.58-1.16-0.77-1.41
Change in Accounts Receivable-1.47-1.52-1.16-0.09-0.03
Change in Accounts Payable0.000.00-1.36-0.691.15
Change in Other Working Capital0.92-0.061.350.87-1.41
Other Operating Activities3.040.78-5.91-3.71-28.34
Net Cash from Operating Activities-1.53-15.70-19.62-21.76-11.34
Investing Activities
Capital Expenditures-0.020.000.00-0.020.00
Purchases of Investments-0.05-1.00-4.000.000.00
Sales/Maturities of Investments0.000.000.00-0.15-0.12
Other Investing Activities0.010.000.00-0.150.00
Net Cash from Investing Activities-0.02-1.00-4.000.13-0.12
Financing Activities
Debt Repayment-0.14-0.12-0.06-0.150.00
Common Stock Issued4.650.020.000.0071.16
Common Stock Repurchased-0.05-0.25-1.320.000.00
Other Financing Activities0.030.140.000.134.30
Net Cash from Financing Activities4.45-0.21-0.06-0.0275.35
Summary
Effect of Forex Changes on Cash-0.37-0.03-0.40-1.980.00
Net Change in Cash2.54-16.94-23.67-23.6463.89
Cash at Beginning of Period1.1818.1242.1965.820.20
Cash at End of Period3.721.1818.1242.1964.09
Free Cash Flow-1.55-15.70-19.62-21.78-11.34
Supplemental Disclosures
Income Taxes Paid-8.780.00-0.49-1.420.00